glp-1 obesity drug news today september 29 2025 The FDA approved a new pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication US FDA tightens control over

This combination of eating less and burning more is what produces the significant weight loss numbers seen in early research

The Basel-based company has confirmed that a new semaglutide generic has been granted marketing authorisation in Brazil, according to a press release issued on Wednesday

Shimu group is a comprehensive high-tech enterprise specialized in R&D, production, marketing and technical service

Inside our cells is the key to lifelong health and healing power that exceeds any manmade medicine on earth

Oxytetracycline and Lidocaine Injection Contact Supplier Product Highlights Broad-Spectrum Efficacy: Effective against gram-positive/negative bacteria, rickettsia, and mycoplasma in various livestock